310 related articles for article (PubMed ID: 12421153)
1. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga JA; Alberio L
J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
[TBL] [Abstract][Full Text] [Related]
9. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
10. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Moake JL
Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Baker KR; Moake JL
Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
[TBL] [Abstract][Full Text] [Related]
13. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
14. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
[TBL] [Abstract][Full Text] [Related]
17. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
[TBL] [Abstract][Full Text] [Related]
18. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
[TBL] [Abstract][Full Text] [Related]
19. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
20. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
